D. Takou

J. Dorfman, W. Burgers, D. Martin, 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

Francesco Montella, Claudia Alteri, Vanni Borghi, 2017, Journal of Clinical Microbiology.

Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status

C. Montesano, Y. Boum, V. Colizzi, 2023, Frontiers in Immunology.

Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2018, Medicine.

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Viruses.

Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Microbiology spectrum.

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, Diagnostic microbiology and infectious disease.

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2021, The Journal of antimicrobial chemotherapy.

HIV-1 Drug Resistance and Genetic Diversity among Vertically Infected Cameroonian Children and Adolescents

V. Colizzi, F. Njiokou, C. Perno, 2020, Exploratory Research and Hypothesis in Medicine.

The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies

F. Ceccherini‐Silberstein, N. Kamgaing, C. Nkenfou, 2023, PloS one.

Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon

V. Colizzi, C. Fokunang, C. Perno, 2020, AIDS Research and Therapy.

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2019, BMC Infectious Diseases.

HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design.

F. Ceccherini‐Silberstein, V. Colizzi, J. Eberle, 2016, Current HIV research.

Evaluation of archived drug resistance mutations in HIV‐1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID‐19 pandemic

F. Ceccherini‐Silberstein, Y. Boum, V. Colizzi, 2023, HIV medicine.

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, Scientific Reports.

Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon

G. Alemnji, J. Torimiro, A. Nanfack, 2013, PloS one.

Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2022, The Journal of antimicrobial chemotherapy.

Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa

E. Buratti, L. De Conti, C. Stuani, 2021, EClinicalMedicine.

HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Crosssectional Design

F. Ceccherini‐Silberstein, V. Colizzi, J. Eberle, 2017 .

Challenges faced by the HIV testing system in low- and middle-income countries

A. Nanfack, J. Fokam, A. Ndjolo, 2023, African Journal of Laboratory Medicine.

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics

V. Colizzi, C. Perno, S. Billong, 2023, Medicine.

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens

F. Ceccherini‐Silberstein, V. Colizzi, C. Fokunang, 2023, Viruses.

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé

V. Colizzi, A. Nanfack, J. Fokam, 2019, BMC Research Notes.

COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon

V. Colizzi, K. C. Nwosu, O. Keiser, 2023, PLOS global public health.

Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies

F. Ceccherini‐Silberstein, C. Montesano, V. Colizzi, 2023, Frontiers in immunology.

Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa

F. Ceccherini‐Silberstein, V. Colizzi, M. Santoro, 2024, Journal of virus eradication.

Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2023, BMJ Open.

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens

F. Ceccherini‐Silberstein, V. Colizzi, C. Perno, 2023, Viruses.

HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study

V. Colizzi, C. Perno, M. Santoro, 2023, PloS one.

Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in Cameroon

V. Colizzi, J. Fokam, A. Ndjolo, 2024, Heliyon.

Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness

V. Colizzi, J. Fokam, A. Ndjolo, 2024, Frontiers in public health.

Performance of rapid subtyping tools used for the classification of HIV type 1 recombinants isolated from selected countries in west and central Africa

J. Torimiro, W. Mbacham, J. Fokam, 2016 .